# Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients

> **NCT06238011** · NA · UNKNOWN · sponsor: **Sawanpracharak hospital** · enrollment: 60 (estimated)

## Conditions studied

- CABG

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT06238011
- **Lead sponsor:** Sawanpracharak hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-28
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-05-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06238011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06238011, "Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06238011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*